Onconetix Stock Soars 63.29% on Merger Hopes

On May 16, 2025, Onconetix's stock price surged by 10.67% during the pre-market session, marking a significant rise in investor interest and confidence in the company's prospects.

Onconetix Inc. (NASDAQ:ONCO) experienced a notable increase in its stock price, rising by 63.29% to $0.12 during Wednesday's session. This surge comes despite a significant drop of 85.93% in the share price over the past three months, indicating a potential turnaround in the company's fortunes.

Onconetix Inc. has recently signed a Letter of Intent (LOI) for a potential merger with Ocuvex Therapeutics. This strategic move could significantly impact the company's future, potentially driving further stock price appreciation as investors anticipate the benefits of the merger.